Lewisville, TX (March, 2014) – med fusion, an integrated Molecular Center of Excellence (MCOE) and clinical trials service organization announces their agreement with Highmark Inc. to provide advanced diagnostic laboratory services for Highmark commercial and Medicare Advantage plans.  This agreement allows Highmark members in Pennsylvania and West Virginia access to med fusion’s complete reference laboratory services, as well as complex molecular tests in our three focus areas – Oncology, Women’s Health and Urology.  med fusion  is proud to be a Highmark Inc. provider and excited to offer their members our brand of precision diagnostics.


med fusion is committed to ensuring patients receive responsible personalized medicine in a cost effective manor by partnering with national, regional, and local managed care organizations.  Our agreement with Highmark Inc. further demonstrates that commitment.


About med fusion


med fusion, an integrated Molecular Center of Excellence and clinical trials organization, delivers support to healthcare providers and biotech/pharmaceutical companies to consistently meet the needs of patients.  An industry leader in advanced laboratory diagnostics and support, our full service clinical laboratory includes a dedicated test development and validation team to meet the needs of clients and reference lab services such as pathology and molecular diagnostics. med fusion is committed to facilitate the realization of personalized medicine by specializing in: Oncology, Women’s Health, Urology, and Infectious Disease.  Headquartered in Lewisville, Texas, med fusion offers its specialized services throughout the U.S. To learn more, please visit www.medfusionservices.com.


Media Contact:

Mary Olson